EXCLUSIVE: Eucomed comes out all guns blazing as MEPs admit changes needed to reg text
This article was originally published in Clinica
The European medtech industry is hopeful that Article 22, the biggest bone of contention in the EU Medical Device Regulation text that relates to how high-risk devices will be regulated in the future, could be amended and further improved. This measure, as well as 27 other compromise amendments made to the text, have been voted through by the European Parliament's committee on the environment, public health and food safety (ENVI).
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.